Joel Isaacson & Co., LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Joel Isaacson & Co., LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$399,648
+5.9%
10,4620.0%0.03%
+8.0%
Q2 2023$377,364
-5.6%
10,4620.0%0.02%
-13.8%
Q1 2023$399,544
-32.9%
10,4620.0%0.03%
-37.0%
Q4 2022$595,288
+43.8%
10,4620.0%0.05%
+27.8%
Q3 2022$414,000
-10.0%
10,4620.0%0.04%
-7.7%
Q2 2022$460,000
+2.4%
10,462
-2.7%
0.04%
+18.2%
Q1 2022$449,000
+3.9%
10,7500.0%0.03%
+10.0%
Q4 2021$432,000
-1.1%
10,7500.0%0.03%
-9.1%
Q3 2021$437,000
-10.5%
10,7500.0%0.03%
-13.2%
Q2 2021$488,000
+8.9%
10,7500.0%0.04%
-2.6%
Q1 2021$448,000
+16.7%
10,750
+19.4%
0.04%
+2.6%
Q4 2020$384,000
+1436.0%
9,000
+254.6%
0.04%
+660.0%
Q4 2016$25,000
-19.4%
2,5380.0%0.01%
-16.7%
Q3 2016$31,000
+40.9%
2,5380.0%0.01%
+20.0%
Q2 2016$22,000
-8.3%
2,5380.0%0.01%0.0%
Q1 2016$24,000
-11.1%
2,538
+65.0%
0.01%
-28.6%
Q4 2015$27,000
+28.6%
1,5380.0%0.01%
+16.7%
Q3 2015$21,000
-40.0%
1,5380.0%0.01%
-33.3%
Q2 2015$35,000
+59.1%
1,5380.0%0.01%
+50.0%
Q1 2015$22,0001,5380.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders